KLK3 and prostate carcinoma: Suspicion of the development of an aggressive variant of prostate cancer with low PSA level can be also reflected in carcinoembryonic antigen (CEA) (44) or other clinical manifestations, including lytic bone metastases, bulky lymphadenopathy, exclusive visceral metastases along with short intervals of ADT response (45).